Last reviewed · How we verify
NCT06603493
Headaches: Effects on Sleep, Sensitization, and Psychological Factors
trial testing Assessment of sleep disorders in Headache Disorder in 132 participants. Completed in 19 December 2024.
19 November 2024
Quick facts
| Lead sponsor | Nagihan Acet |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 132 |
| Start date | 19 September 2024 |
| Primary completion | 19 November 2024 |
| Estimated completion | 19 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Assessment of sleep disorders
- Assessment of Central Sensitization
- Assessment of depression, anxiety and stress levels
Conditions studied
- Headache Disorder — all drugs for Headache Disorder →
Sponsor
Nagihan Acet
Who can join
Adults 18 to 65, any sex, with Headache Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Headache is one of the most common health problems in the society and negatively affects the quality of life of individuals. Increasing complaints of headache in recent years can be associated with many physiological and psychological factors. Sleep disturbances are one of these factors. Inadequate or non-restful sleep can interfere with the normal course of physical, mental, social and emotional functions. Impaired sleep quality interferes with the body\'s process of repairing and regenerating itself, which can lead to more serious health problems in the long term. Secondly, headaches can also lead to neurophysiological changes such as central sensitization. Central sensitization causes the nervous system to become hypersensitive, lowering the pain threshold and increasing pain perception. Finally, headache can have psychological effects by increasing levels of depression, anxiety and stress. This study aimed to determine the effects of headache on sleep disturbances, central sensitization, depression, anxiety and stress.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06603493
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nagihan Acet trials
Trials by the same sponsor.
- NCT06689319 — Factors Linked to AI Literacy in University Students · completed
- NCT06634238 — Acute Mask Effects on Walk Distance and Vital Signs · not yet recruiting
- NCT06598774 — Cervical Parameters and Body Awareness in Relation to Smartphone Addiction · completed
- NCT06559397 — Proprioceptive Puzzle: Effects on Quantitative Sensory Tests and Body Awareness · completed
- NCT06558318 — TMJ Dysfunction: Effects on Proprioception, Pain, and Body Awareness · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06603493 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nagihan Acet
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06603493.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing